5O_PRA Phase 1b/2 Study of Omaveloxolone in Combination With Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdx760
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Rechallenge With Checkpoint Inhibitors in Metastatic Melanoma

JDDG - Journal of the German Society of Dermatology
Dermatology
2020English

Results of a Prospective Phase 2 Study of Pazopanib in Patients With Surgically Unresectable or Metastatic Chondrosarcoma

Cancer
Cancer ResearchOncology
2019English

Immune Checkpoint Inhibitors Therapy in Older Patients (≥ 70 Years) With Metastatic Melanoma: A Multicentre Study

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2019English

Recurrent Pneumonitis in Patients With Melanoma Treated With Immune Checkpoint Inhibitors

Oncologist
Cancer ResearchMedicineOncology
2019English

Impact of Clinicopathological Characteristics on Survival in Patients Treated With Immune Checkpoint Inhibitors for Metastatic Melanoma

International Journal of Cancer
Cancer ResearchOncology
2018English

SWOG 0514: A Phase II Study of Sorafenib in Patients With Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma

Investigational New Drugs
OncologyPharmacology
2011English

A Phase 1b Study of Transforming Growth Factor-Beta Receptor I Inhibitor Galunisertib in Combination With Sorafenib in Japanese Patients With Unresectable Hepatocellular Carcinoma

Investigational New Drugs
OncologyPharmacology
2018English

P2.13-08 Phase 1 Study of the AXL Inhibitor DS-1205c in Combination With Osimertinib in Subjects With Metastatic or Unresectable EGFR-Mutant NSCLC.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Phase II Trial of Gemcitabine and Capecitabine in Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma: Southwest Oncology Group Study S0202

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy